Guangdong Hybribio Biotech Co.,Ltd.’s Net Profit Dropped 92.8% in First Three Quarters of 2023

Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) (300639.SZ) reported a net profit of 116.7 million yuan in the first three quarters of 2023, down 92.8% year-on-year.

Meanwhile, the company posted 850.6 million yuan in revenue, down 80% year-on-year.

At the end of the reporting period, it had 6.1 billion yuan in total assets and 937.8 million yuan in total liabilities, with a liability-to-asset ratio of 15.4%.